Impact of injection interval on patient satisfaction in the routine treatment of cervical dystonia with abobotulinumtoxinA
Objective: Evaluate the impact of injection interval on patient satisfaction with abobotulinumtoxinA (AboBoNT-A; Dysport®) over 1 injection cycle in patients with cervical dystonia (CD). Background:…Injection guidance use in the management of cervical dystonia with botulinum toxin
Objective: Investigate the use of injection guidance techniques and their impact on patient outcomes in the routine management of cervical dystonia (CD) with botulinum neurotoxin…Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients
Objective: To study the efficacy of GPi DBS surgery in improving dystonia related severity, disability and pain as well as quality of life in medically…Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm
Objective: The two primary objectives of this study were to investigate the structural grey matter changes and connectivity differences between patients with BEB and HFS…Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
Objective: To trace a clinical and epidemiological profile of patients treated with botulinum toxin, evaluating the impact on quality of life. Background: The Botulinum Toxin…Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients
Objective: To prospectively assess the interval in weeks between injection of botulinum toxin A (BoNTA) and patient-perceived need for the next injection for treatment of…Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm
Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…Botulinum neurotoxin type A versus anticholinergics for cervical dystonia in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To compare the effects of botulinum toxin A (BtA) versus anticholinergics in adults with cervical dystonia (CD). Background: This is an update of a…Highlighting the spectrum of practice in the routine management of cervical dystonia with botulinum neurotoxin-A: Baseline injection practice data from MetaCD
Objective: To describe the spectrum of routine injection practice for botulinum neurotoxin-A (BoNT-A) in the management of cervical dystonia (CD). Background: The success of each…Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update
Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to placebo in adults with hemifacial spasm (HFS). Background: This is an update…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.